These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14714543)

  • 21. Effect of artemisinin-based treatment policy on consumption pattern of antimalarials.
    Mokuolu OA; Okoro EO; Ayetoro SO; Adewara AA
    Am J Trop Med Hyg; 2007 Jan; 76(1):7-11. PubMed ID: 17255221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controlling malaria: challenges and solutions.
    Olliaro P; Taylor WR; Rigal J
    Trop Med Int Health; 2001 Nov; 6(11):922-7. PubMed ID: 11703847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reflections on the 'discovery' of the antimalarial qinghao.
    Hsu E
    Br J Clin Pharmacol; 2006 Jun; 61(6):666-70. PubMed ID: 16722826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Qinghaosu in combinations.
    White NJ
    Med Trop (Mars); 1998; 58(3 Suppl):85-8. PubMed ID: 10212909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The quest for universal access to effective malaria treatment: how can the AMFm contribute?
    Matowe L; Adeyi O
    Malar J; 2010 Oct; 9():274. PubMed ID: 20932286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Public health. From financing to fevers: lessons of an antimalarial subsidy program.
    Laxminarayan R; Arrow K; Jamison D; Bloom BR
    Science; 2012 Nov; 338(6107):615-6. PubMed ID: 23118173
    [No Abstract]   [Full Text] [Related]  

  • 27. Estimating the needs for artesunate-based combination therapy for malaria case-management in Africa.
    Snow RW; Eckert E; Teklehaimanot A
    Trends Parasitol; 2003 Aug; 19(8):363-9. PubMed ID: 12901938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Artemesinins for severe malaria in Africa?
    Marsh K
    East Afr Med J; 2002 Dec; 79(12):619-20. PubMed ID: 12678444
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthetic biology's first malaria drug meets market resistance.
    Peplow M
    Nature; 2016 Feb; 530(7591):389-90. PubMed ID: 26911755
    [No Abstract]   [Full Text] [Related]  

  • 30. Global health. Malaria drugs, the Coca-Cola way.
    Enserink M
    Science; 2008 Nov; 322(5905):1174. PubMed ID: 19023050
    [No Abstract]   [Full Text] [Related]  

  • 31. Underpricing the competition in the other drug war: a novel strategy for combatting the inappropriate use of artemisinin monotherapies.
    Gill CJ; Hamer DH
    Pathog Glob Health; 2013 Apr; 107(3):108-9. PubMed ID: 23683363
    [No Abstract]   [Full Text] [Related]  

  • 32. Rolling back malaria: opportunities and challenges.
    Nafo Traoré F
    Trans R Soc Trop Med Hyg; 2005 Jun; 99(6):403-6. PubMed ID: 15837351
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of malaria: outlook].
    Olliaro P; Brasseur P
    Bull Acad Natl Med; 2007 Oct; 191(7):1285-92. PubMed ID: 18447050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in availability and prices of subsidized ACT over the first year of the AMFm: evidence from remote regions of Tanzania.
    Yadav P; Cohen JL; Alphs S; Arkedis J; Larson PS; Massaga J; Sabot O
    Malar J; 2012 Aug; 11():299. PubMed ID: 22929587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimalarial treatment with artemisinin combination therapy in Africa.
    Malenga G; Palmer A; Staedke S; Kazadi W; Mutabingwa T; Ansah E; Barnes KI; Whitty CJ
    BMJ; 2005 Oct; 331(7519):706-7. PubMed ID: 16195260
    [No Abstract]   [Full Text] [Related]  

  • 36. Artemisinin combination therapies.
    Duffy PE; Mutabingwa TK
    Lancet; 2006 Jun; 367(9528):2037-9. PubMed ID: 16798368
    [No Abstract]   [Full Text] [Related]  

  • 37. A cost-effectiveness analysis of three antimalarial treatments for acute, uncomplicated Plasmodium falciparum malaria in Mumbai, India.
    Gogtay NJ; Kadam VS; Desai S; Kamtekar KD; Dalvi SS; Kshirsagar NA
    J Assoc Physicians India; 2003 Sep; 51():877-9. PubMed ID: 14710972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is combination therapy for malaria based on user-fees worthwhile and equitable to consumers? Assessment of costs and willingness to pay in Southeast Nigeria.
    Onwujekwe O; Uzochukwu B; Shu E; Ibeh C; Okonkwo P
    Acta Trop; 2004 Jul; 91(2):101-15. PubMed ID: 15234659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Review of the use of artemisinin and its derivatives in the treatment of malaria].
    Van der Meersch H
    J Pharm Belg; 2005; 60(1):23-9. PubMed ID: 15828489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Artemisinin, a novel antimalarial drug: biochemical and molecular approaches for enhanced production.
    Abdin MZ; Israr M; Rehman RU; Jain SK
    Planta Med; 2003 Apr; 69(4):289-99. PubMed ID: 12709893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.